V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280005728 | 280003602 | 1.9 | 68.6 | Palliative (P) | 2016-02-04 | 2016-04-01 | Oxaliplatin + Modified de Gramont | 02 | N | 280029598 | KESTREL TRIAL |
| 280005729 | 280003602 | 1.88 | 110.7 | null | 2015-06-22 | 2015-06-23 | ECX | N | N | 280029598 | PAZOPANIB |
| 280005730 | 280010038 | 1.77 | 69.3 | Palliative (P) | 2016-06-13 | 2016-06-17 | Capecitabine | 02 | N | 280029603 | DOXORUBICIN + OLARATUMAB |
| 280005731 | 280010038 | 1.57 | 51.1 | Curative (C) | 2013-04-01 | 2013-04-19 | Cyclophosphamide oral | 2 | N | 280029603 | CISPLATIN + ETOPOSIDE |
| 280005732 | 280003603 | 1.64 | 108.65 | Curative (C) | 2016-03-24 | 2016-10-13 | Mitomycin Intravesical | null | null | 280029608 | IVA |
| 280005733 | 280007932 | 1.76 | 100.2 | Palliative (P) | 2014-04-14 | 2014-04-22 | Cisplatin + Doxorubicin | N | null | 280029609 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 280005734 | 280007932 | 1.64 | 96 | Neo-adjuvant (N) | 2013-06-29 | 2013-06-29 | PACLITAXEL | N | N | 280029609 | IFOSFAMIDE |
| 280005735 | 280003604 | null | 60.6 | Palliative (P) | 2013-07-11 | 2013-07-31 | FLUOROURACIL + MITOMYCIN + RT | N | N | 280029612 | CARBO + FLUOROURACIL |
| 280005736 | 280003604 | 1.72 | 65.8 | Palliative (P) | 2017-08-31 | 2017-09-13 | VINCRISTINE | N | Y | 280029612 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280005737 | 280003604 | 1.79 | 74 | Palliative (P) | 2013-04-24 | 2013-05-28 | CARBOPLATIN + GEMCITABINE | 02 | Y | 280029612 | CISPLATIN + FLUOROURACIL + RT |
| 280005738 | 280003604 | 1.63 | 0 | Adjuvant (A) | 2014-06-23 | 2014-06-23 | GemCarbo Days 1+8 | 02 | N | 280029612 | CISPLATIN + VINORELBINE |
| 280005739 | 280003605 | 1.65 | null | Curative (C) | 2014-05-31 | 2014-06-06 | Carbo F | Y | null | 280029618 | EURO-EWING |
| 280005740 | 280007934 | 1.75 | 79.8 | Neo-adjuvant (N) | 2013-05-11 | 2013-05-31 | Oxaliplatin + Modified de Gramont | N | N | 280029620 | SUNITINIB |
| 280005741 | 280003606 | 1.61 | 70.3 | Palliative (P) | 2015-07-23 | 2015-08-23 | Capecitabine | N | N | 280029622 | DOXORUBICIN + OLARATUMAB |
| 280005742 | 280003606 | 1.6 | 70.1 | Curative (C) | 2013-09-12 | 2013-10-03 | Docetaxel+Gemcitabine (no prior RT) | N | N | 280029622 | CISPLATIN + FLUOROURACIL + RT |
| 280005743 | 280003607 | 1.7 | null | Curative (C) | 2017-04-05 | 2017-04-20 | IPILIMUMAB + NIVOLUMAB | 02 | N | 280029627 | CISPLATIN + VINORELBINE |
| 280005744 | 280003608 | 1.73 | 56 | Palliative (P) | 2015-03-05 | 2015-03-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 280029628 | HYDROXYCARBAMIDE |
| 280005745 | 280003608 | 1.65 | null | Adjuvant (A) | 2016-01-25 | 2016-01-26 | ECX | N | null | 280029628 | PATHOS TRIAL |
| 280005746 | 280003609 | 1.66 | 65 | Curative (C) | 2015-05-17 | 2015-05-17 | Trabectedin | N | N | 280029631 | EURO-EWING |
| 280005747 | 280003609 | 1.61 | 53 | Palliative (P) | 2018-02-19 | 2018-02-22 | Carboplatin + Pemetrexed | 2 | N | 280029631 | DOXORUBICIN + OLARATUMAB |
| 280005748 | 280003610 | 1.77 | 71 | Not known (9) | 2017-08-21 | 2017-09-22 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 280029633 | CAPECITABINE + CARBOPLATIN |
| 280005749 | 280003611 | 1.81 | 66 | Palliative (P) | 2017-04-19 | 2017-05-03 | Capecitabine + Cisplatin | 2 | N | 280029635 | TRABECTEDIN |
| 280005750 | 280003611 | 1.78 | 100 | Adjuvant (A) | 2013-06-11 | 2013-06-17 | CARBOPLATIN + VINORELBINE | 02 | N | 280029635 | CISPLATIN + VINORELBINE |
| 280005751 | 280010041 | 1.67 | 79.5 | null | 2017-07-17 | 2017-07-19 | EpSSG NRSTS 2005 | N | N | 280029637 | MELPHALAN |
| 280005752 | 280011092 | 1.08 | null | Palliative (P) | 2017-08-08 | 2017-08-08 | CAPECITABINE + GEMCITABINE | 02 | N | 280029639 | ABIRATERONE |
| 280005753 | 280011605 | null | 89.1 | Palliative (P) | 2017-06-13 | 2017-06-13 | Cisplatin + Fluorouracil + RT 5day | Y | N | 280029640 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 280005754 | 280003612 | 0 | 0 | Adjuvant (A) | 2016-06-27 | 2016-06-30 | GEMCITABINE | N | N | 280029641 | PATHOS TRIAL |
| 280005755 | 280003613 | 1.86 | 65 | Neo-adjuvant (N) | 2017-05-22 | 2017-06-13 | Capecitabine | 02 | N | 280029642 | EURO-EWING |
| 280005756 | 280003614 | 1.61 | 59.4 | Palliative (P) | 2015-04-05 | 2015-04-22 | Carboplatin + Cetux + FU (Cycle 1) | N | N | 280029643 | TRABECTEDIN |
| 280005757 | 280003615 | 1.72 | 0 | Palliative (P) | 2017-01-31 | 2017-02-04 | EVEROLIMUS | N | N | 280029644 | CARBOPLATIN + PEMETREXED |
| 280005758 | 280003616 | 1.69 | 78 | Curative (C) | null | 2016-12-28 | Cisplatin + Etoposide (3 day) | N | N | 280029645 | IVADO |
| 280005759 | 280007939 | 1.85 | 116.699 | Palliative (P) | 2014-05-19 | 2014-05-23 | Cisplatin + Fluorouracil + RT 5day | N | null | 280029646 | LIPOSOMAL DOXORUBICIN |
| 280005760 | 280003617 | null | 61.1 | Palliative (P) | 2015-05-01 | 2015-05-01 | CARBOPLATIN + GEMCITABINE | 02 | N | 280029647 | CARBO + FLUOROURACIL |
| 280005761 | 280003617 | 1.61 | null | Palliative (P) | 2014-09-18 | 2014-09-18 | Carbo F | N | N | 280029647 | DOXORUBICIN + OLARATUMAB |
| 280005762 | 280003617 | 1.61 | 52 | Adjuvant (A) | null | 2016-12-18 | OCTREOTIDE | null | N | 280029647 | CISPLATIN + DOXORUBICIN |
| 280005763 | 280003617 | 0 | null | Curative (C) | 2016-10-10 | 2016-10-10 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 280029647 | IVA |
| 280005764 | 280003617 | 1.79 | 85.2 | Palliative (P) | 2017-04-13 | 2017-04-20 | CHOP R - 21 days | N | N | 280029647 | CISPLATIN + FLUOROURACIL + RT |
| 280005766 | 280003619 | 1.75 | 78.8 | Palliative (P) | null | 2017-10-31 | CompARE Trial | null | null | 280029658 | CARBO + FLUOROURACIL |
| 280005767 | 280003619 | null | 80.8 | Palliative (P) | 2014-10-22 | 2014-10-25 | Oxaliplatin + Modified de Gramont | N | N | 280029658 | CEDIRANIB |
| 280005768 | 280003620 | 1.77 | 80 | Palliative (P) | 2013-08-19 | 2013-08-24 | Oxaliplatin + Modified de Gramont | N | N | 280029660 | BRENTUXIMAB |
| 280005769 | 280003620 | 1.75 | 65.6 | Palliative (P) | 2015-08-05 | 2015-08-11 | VIDE | 2 | N | 280029660 | TRABECTEDIN |
| 280005770 | 280003620 | null | 67 | Neo-adjuvant (N) | 2016-07-15 | 2016-07-22 | CETUXIMAB + CISPLATIN + FU | Y | null | 280029660 | DOXORUBICIN + HD MTX |
| 280005771 | 280003621 | 1.71 | null | Curative (C) | 2013-11-22 | 2013-11-25 | Liposomal Doxorubicin (Caelyx) | 02 | N | 280029663 | IVA |
| 280005772 | 280007943 | 0 | 73 | Palliative (P) | 2015-05-01 | 2015-05-09 | EW EuroEwing 99 : VIDE | N | N | 280029664 | CAPECITABINE + CISPLATIN |
| 280005773 | 280003622 | null | null | Curative (C) | 2017-12-20 | 2017-12-29 | VIDE | 02 | null | 280029667 | DE-ESCALATE TRIAL |
| 280005774 | 280007944 | null | null | Neo-adjuvant (N) | 2014-03-31 | 2014-04-05 | EW EuroEwing 99 : VIDE | N | N | 280029668 | CAPECITABINE + RT |
| 280005775 | 280003623 | 1.79 | null | Palliative (P) | null | 2014-01-09 | Bortezomib + CYCLOPHOSPHAMIDE + Dexamethasone | null | null | 280029672 | LIPOSOMAL DOXORUBICIN |
| 280005776 | 280007945 | 1.73 | 115.7 | Curative (C) | null | 2016-06-26 | FLUOROURACIL + MITOMYCIN | null | null | 280029673 | CAPECITABINE + MITOMYCIN |
| 280005777 | 280003624 | null | 58.6 | Palliative (P) | null | 2017-06-10 | Irinotecan + Modified De Gramont | null | null | 280029674 | IVA |
| 280005778 | 280003624 | 1.78 | null | Neo-adjuvant (N) | 2017-08-04 | 2017-09-01 | Trabectedin | N | n | 280029674 | PACLITAXEL |